Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iTonic HoldingsITOC 14 EV-to-EBIT is -0.81 as of Aug. 05, 2026. GuruFocus rates ITOC with a GF Score™ of 14/100. The stock has 6 warning signs investors should review. Among 470 Medical Devices & Instruments companies, iTonic Holdings ranks worse than 212765.74% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
iTonic Holdings's Enterprise Value for the quarter that ended in Dec. 2025 was $6.39 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. iTonic Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-5.17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iTonic Holdings EV-to-EBIT Related Terms
iTonic Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for iTonic Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, iTonic Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iTonic Holdings EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iTonic Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where iTonic Holdings's EV-to-EBIT falls into.
iTonic Holdings's current Enterprise Value is $4.17 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. iTonic Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-5.17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iTonic Holdings (ITOC) has a EV-to-EBIT of -0.81 as of Aug. 05, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on iTonic Holdings and its competitors. According to the industry distribution chart, iTonic Holdings ranks #999999 out of 470 companies in the Medical Devices & Instruments industry.
Is iTonic Holdings' EV-to-EBIT too high?
iTonic Holdings' current EV-to-EBIT is -0.81. Based on the distribution chart, iTonic Holdings ranks #999999 out of 470 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iTonic Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does iTonic Holdings' EV-to-EBIT compare to USAQ and ALURD?
According to the Medical Devices & Instruments industry distribution chart, iTonic Holdings ranks #999999 out of 470 companies for EV-to-EBIT. This places iTonic Holdings in the lower half of its industry. The industry median EV-to-EBIT is 19.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.07, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on iTonic Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iTonic Holdings's current EV-to-EBIT is -0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iTonic Holdings stock overvalued right now?
iTonic Holdings (ITOC) has a current EV-to-EBIT of -0.81. The current EV-to-EBIT is -0.81. iTonic Holdings' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For iTonic Holdings (ITOC), the current EV-to-EBIT is -0.81 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
14GF Score
Get the complete analysis for ITOC
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ITOC has been successfully added to your 
